Translational paradigm of advanced nanoscale strategies for triple negative breast cancer (TNBC): mechanistic insights, metastatic pathways, and emerging theragnosis

Materials Advances 2026 Open access

Read full text
Authors: Soumya Sonalisha, Apoorv Kirti, SP. Asima, Richeek Parashar, Srijeeta Pal, Debidutta Barik, Shaikh Sheeran Naser, Eliana B. Souto, Suresh K. Verma
DOI: 10.1039/d5ma00866b
Cited by: 3
References: 186

Abstract

Triple-negative breast cancer (TNBC) progression involves pathogenicity, metastatic dissemination, and molecular dysregulation. Advanced therapies offer targeted strategies to inhibit tumor growth, reduce metastasis, and improve therapeutic efficacy.

Fields of Study & Subjects

Nanoparticle-Based Drug Delivery Cancer Research and Treatment Cancer Research and Treatments

Publication details

Journal / source
Materials Advances
Publisher
Royal Society of Chemistry (RSC)
Volume
7
Issue
6
Pages
3072–3100
Publication date
1 January 2026
Language
EN